VERVE-101 - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Saudi Arabia unveils 14-country maritime coalition to protect Red Sea shipping

WSP Global’s second Arcadis approach fails on price and paper currency concerns

Pakistan coal mine explosion kills at least 32 as rescuers search for 10 trapped workers

Representative image of PCSK9 inhibitor drug development across leading pharmaceutical companies in 2025

Read More

Pharma Industry News

Top 5 PCSK9 inhibitor stocks to watch in 2025: From injectables to gene editing

Explore the top five PCSK9 inhibitor stocks—Amgen, Regeneron–Sanofi, Merck, Novartis, Verve—and what makes each a standout in cholesterol treatment in 2025.

byPallavi Madhiraju

June 11, 2025

web analytics